Latest Insider Transactions at Cel Sci Corp (CVM)
This section provides a real-time view of insider transactions for Cel Sci Corp (CVM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CEL SCI CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CEL SCI CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,940
+1.05%
|
$0
$0.4 P/Share
|
|
Dec 31
2024
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,001
+4.6%
|
$0
$0.4 P/Share
|
|
Dec 31
2024
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,727
+4.1%
|
$0
$0.4 P/Share
|
|
Sep 30
2024
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,264
+1.87%
|
$2,264
$1.06 P/Share
|
|
Sep 30
2024
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,047
+1.66%
|
$4,047
$1.06 P/Share
|
|
Sep 30
2024
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,882
+0.4%
|
$4,882
$1.06 P/Share
|
|
Jun 28
2024
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,068
+1.75%
|
$2,068
$1.16 P/Share
|
|
Jun 28
2024
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,461
+0.37%
|
$4,461
$1.16 P/Share
|
|
Jun 28
2024
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,698
+1.54%
|
$3,698
$1.16 P/Share
|
|
May 08
2024
|
Robert Eugene Watson Director |
BUY
Open market or private purchase
|
Direct |
20,000
+45.01%
|
$20,000
$1.39 P/Share
|
|
May 08
2024
|
Patricia B Prichep Chief Financial & Operations |
BUY
Open market or private purchase
|
Direct |
8,000
+3.33%
|
$8,000
$1.39 P/Share
|
|
May 08
2024
|
Geert R Kersten CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+2.45%
|
$30,000
$1.39 P/Share
|
|
Mar 29
2024
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+0.99%
|
$2,246
$1.91 P/Share
|
|
Mar 29
2024
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,256
+1.09%
|
$1,256
$1.91 P/Share
|
|
Mar 29
2024
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,709
+0.23%
|
$2,709
$1.91 P/Share
|
|
Dec 29
2023
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
882
+0.77%
|
$1,764
$2.72 P/Share
|
|
Dec 29
2023
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,819
+0.16%
|
$3,638
$2.72 P/Share
|
|
Dec 29
2023
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,577
+0.71%
|
$3,154
$2.72 P/Share
|
|
Sep 29
2023
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,432
+1.53%
|
$3,432
$1.25 P/Share
|
|
Sep 29
2023
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,920
+1.68%
|
$1,920
$1.25 P/Share
|
|
Sep 29
2023
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,960
+0.34%
|
$3,960
$1.25 P/Share
|
|
Jun 30
2023
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
995
+0.89%
|
$1,990
$2.41 P/Share
|
|
Jun 30
2023
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,053
+0.18%
|
$4,106
$2.41 P/Share
|
|
Jun 30
2023
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,780
+0.81%
|
$3,560
$2.41 P/Share
|
|
Mar 31
2023
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+0.94%
|
$2,068
$2.32 P/Share
|
|
Mar 31
2023
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,133
+0.18%
|
$4,266
$2.32 P/Share
|
|
Mar 31
2023
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,849
+0.85%
|
$3,698
$2.32 P/Share
|
|
Dec 30
2022
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,851
+0.16%
|
$3,702
$2.35 P/Share
|
|
Dec 30
2022
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,825
+0.85%
|
$3,650
$2.35 P/Share
|
|
Dec 30
2022
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,021
+0.94%
|
$2,042
$2.35 P/Share
|
|
Sep 30
2022
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,266
+1.04%
|
$3,798
$3.09 P/Share
|
|
Sep 30
2022
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
776
+0.72%
|
$2,328
$3.09 P/Share
|
|
Sep 30
2022
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,388
+0.65%
|
$4,164
$3.09 P/Share
|
|
Sep 30
2022
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,407
+0.12%
|
$4,221
$3.09 P/Share
|
|
Jun 30
2022
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
876
+0.73%
|
$3,504
$4.5 P/Share
|
|
Jun 30
2022
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
533
+0.5%
|
$2,132
$4.5 P/Share
|
|
Jun 30
2022
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
953
+0.45%
|
$3,812
$4.5 P/Share
|
|
Jun 30
2022
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
966
+0.08%
|
$3,864
$4.5 P/Share
|
|
Mar 31
2022
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,106
+0.1%
|
$3,318
$3.93 P/Share
|
|
Mar 31
2022
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,091
+0.52%
|
$3,273
$3.93 P/Share
|
|
Mar 31
2022
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
610
+0.57%
|
$1,830
$3.93 P/Share
|
|
Mar 31
2022
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,006
+0.84%
|
$3,018
$3.93 P/Share
|
|
Dec 31
2021
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
612
+0.05%
|
$4,284
$7.1 P/Share
|
|
Dec 31
2021
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
604
+0.29%
|
$4,228
$7.1 P/Share
|
|
Dec 31
2021
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+0.32%
|
$2,366
$7.1 P/Share
|
|
Dec 31
2021
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
557
+0.47%
|
$3,899
$7.1 P/Share
|
|
Oct 19
2021
|
Eyal Talor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-12.51%
|
$165,000
$11.25 P/Share
|
|
Sep 30
2021
|
Geert R Kersten CEO |
BUY
Grant, award, or other acquisition
|
Direct |
395
+0.03%
|
$3,950
$10.99 P/Share
|
|
Sep 30
2021
|
Patricia B Prichep Chief Financial & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
372
+0.18%
|
$3,720
$10.99 P/Share
|
|
Sep 30
2021
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
218
+0.18%
|
$2,180
$10.99 P/Share
|